Please use this identifier to cite or link to this item: http://sgc.anlis.gob.ar/handle/123456789/1460
DC FieldValueLanguage
dc.contributor.authorVillar, Juan Carloses
dc.contributor.authorPerez, Juan Guillermoes
dc.contributor.authorCortes, Olga Luciaes
dc.contributor.authorRiarte, Adelinaes
dc.contributor.authorPepper, Micahes
dc.contributor.authorMarin-Neto, José Antônioes
dc.contributor.authorGuyatt, Gordon Hes
dc.date.accessioned2019-12-05T20:06:16Z-
dc.date.available2019-12-05T20:06:16Z-
dc.date.issued2014-05-27-
dc.identifier.issn1465-1858-
dc.identifier.urihttp://sgc.anlis.gob.ar/handle/123456789/1460-
dc.identifier.urihttps://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003463.pub2/full-
dc.descriptionFil: Villar, Juan Carlos. Department of Medicine, Universidad Autónoma de Bucaramanga; Colombia.es
dc.descriptionFil: Perez, Juan Guillermo. Fundación Cardioinfantil Instituto de Cardiología, Bogota; Colombia.es
dc.descriptionFil: Cortes, Olga Lucia. Fundación Cardioinfantil Instituto de Cardiología, Bogota; Colombiaes
dc.descriptionFil: Riarte, Adelina. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Parasitología; Argentina.es
dc.descriptionFil: Pepper, Micah. School of Public Health, Boston University, Boston; Estados Unidos.es
dc.descriptionFil: Marin-Neto, José Antônio. Medical School of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto; Brasil.es
dc.descriptionFil: Guyatt, Gordon H. Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton; Canada.es
dc.description.abstractPrevention of chronic chagasic cardiomyopathy (CCC) by treating infected populations with trypanocidal therapy (TT) remains a challenge. Despite a renewed enthusiasm for TT, uncertainty regarding its efficacy, concerns about its safety and limited availability remain barriers for a wider use of conventional drugs. We have updated a previous version of this review.es
dc.language.isoenes
dc.publisherWileyes
dc.relation.ispartofThe Cochrane database of systematic reviewses
dc.rightsClosed Access-
dc.sourceThe Cochrane database of systematic reviews 2014; 27.-
dc.subjectTripanocidases
dc.subjectTrypanosoma cruzies
dc.titleTrypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infectiones
dc.typeArtículoes
dc.identifier.doi10.1002/14651858.CD003463.pub2-
anlis.essnrd1-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairetypeArtículo-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptAdministración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán” (ANLIS)-
crisitem.author.deptInstituto Nacional de Parasitología (INP)-
crisitem.author.parentorgAdministración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán” (ANLIS)-
Appears in Collections:Publicaciones INP
Show simple item record

Page view(s)

38
checked on Apr 26, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.